These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 1662552
21. Novel synthetic retinoids and separation of the pleiotropic retinoidal activities. Kagechika H. Curr Med Chem; 2002 Mar; 9(5):591-608. PubMed ID: 11945126 [Abstract] [Full Text] [Related]
22. Regulation of gene expression by nuclear hormone receptors. Meier CA. J Recept Signal Transduct Res; 1997 Mar; 17(1-3):319-35. PubMed ID: 9029499 [Abstract] [Full Text] [Related]
23. Retinoid receptors and their coregulators. Wei LN. Annu Rev Pharmacol Toxicol; 2003 Mar; 43():47-72. PubMed ID: 12142470 [Abstract] [Full Text] [Related]
34. Retinobenzoic acids. 3. Structure-activity relationships of retinoidal azobenzene-4-carboxylic acids and stilbene-4-carboxylic acids. Kagechika H, Himi T, Namikawa K, Kawachi E, Hashimoto Y, Shudo K. J Med Chem; 1989 May 31; 32(5):1098-108. PubMed ID: 2709376 [Abstract] [Full Text] [Related]
35. Mechanism of action of retinoids. Sporn MB, Roberts AB, Roche NS, Kagechika H, Shudo K. J Am Acad Dermatol; 1986 Oct 31; 15(4 Pt 2):756-64. PubMed ID: 3021829 [Abstract] [Full Text] [Related]
36. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. Kagechika H, Kawachi E, Hashimoto Y, Himi T, Shudo K. J Med Chem; 1988 Nov 31; 31(11):2182-92. PubMed ID: 3184125 [Abstract] [Full Text] [Related]
37. Retinoids as critical modulators of immune functions: new therapeutic perspectives for old compounds. Montrone M, Martorelli D, Rosato A, Dolcetti R. Endocr Metab Immune Disord Drug Targets; 2009 Jun 31; 9(2):113-31. PubMed ID: 19519462 [Abstract] [Full Text] [Related]
38. Retinoid-enhanced alveolization: identifying relevant downstream targets. Pierce RA, Michael Shipley J. Am J Respir Cell Mol Biol; 2000 Aug 31; 23(2):137-41. PubMed ID: 10919977 [No Abstract] [Full Text] [Related]
39. Structural development of biological response modifiers based on retinoids and thalidomide. Hashimoto Y. Mini Rev Med Chem; 2002 Dec 31; 2(6):543-51. PubMed ID: 12370039 [Abstract] [Full Text] [Related]
40. [Chemical control of gene expression]. Hashimoto Y. Yakugaku Zasshi; 1994 Jun 31; 114(6):357-73. PubMed ID: 8051626 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]